02 April 2024 LEQVIO®, A FIRST-IN-CLASS siRNA THERAPY FOR LDL-C LOWERING, NOW LISTED ON THE PBS – Novartis Australia and New Zealand 0 minute read Pharmacy By Cate Swannell Previous Post Next Post